Showing results (421-430 of 500) with videos related to

Sort By:
Pageof 50
Gastroenterology|December 1, 1983
Treatment of Crohn's disease with peroral 5-aminosalicylic acidS N Rasmussen, V Binder, K Maier, et al.
Clinical Endocrinology|January 1, 1979
L-thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volumeJ M Hansen, J Kampmann, S N Madsen, et al.
Acta Anaesthesiologica Scandinavica|February 6, 2013
Laryngeal morbidity after tracheal intubation: the Endoflex(®) tube compared to conventional endotracheal intubation with styletM K Sørensen, N Rasmussen, M S Kristensen, et al.
Digestive Diseases and Sciences|October 1, 1993
Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal childrenL A Christensen, J Fallingborg, B A Jacobsen, et al.
The EPMA Journal|January 30, 2016
Utilization of the clinical laboratory for the implementation of concussion biomarkers in collegiate football and the necessity of personalized and predictive athlete specific reference intervalsStefanie Schulte, Natalie N Rasmussen, Joseph W McBeth, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1990
Gastrointestinal pH and transit times in healthy subjects with ileostomyJ Fallingborg, L A Christensen, M Ingeman-Nielsen, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1994
Comparative bioavailability of 5-aminosalicylic acid from a controlled release preparation and an azo-bond preparationL A Christensen, J Fallingborg, B A Jacobsen, et al.
Ergonomics|August 18, 2011
Participation of Danish and immigrant cleaners in a 1-year worksite intervention preventing physical deteriorationCharlotte D N Rasmussen, Marie B Jørgensen, Isabella G Carneiro, et al.
Scandinavian Journal of Gastroenterology|June 1, 1994
Effect of olsalazine and mesalazine on intraluminal pH of the duodenum and proximal jejunum in healthy humansJ Fallingborg, L A Christensen, B A Jacobsen, et al.
Scandinavian Journal of Gastroenterology|April 1, 1991
Availability of mesalazine (5-aminosalicylic acid) from enemas and suppositories during steady-state conditionsB A Jacobsen, K Abildgaard, H H Rasmussen, et al.
Pageof 50